Best CAR-T CDMOs in United States

← All CAR-T CDMOs Best Clean FDA History Commercial Scale

Region: USA Europe Asia

CDMOs tracked

Fully scored

With FDA records

FDA inspections

EMA/MHRA GMP certs

For US-manufactured car-t programs, Charles River Laboratories, Bristol Myers Squibb (CGT Mfg), and City of Hope (T Cell Manufacturing) lead CDMO Signal's ranking of car-t CDMOs with confirmed US facilities. Filtered from the global directory of 31 scored car-t CDMOs to 17 with US manufacturing presence. US-based manufacturing carries specific advantages for sponsors filing under FDA jurisdiction: FDA inspection records — which form the core of the Signal Score's Quality Compliance pillar — apply directly, and QP release complexity common to EU-manufactured material does not apply. Rankings update as new inspection and certificate data enters the platform. Full methodology at cdmosignal.com/methodology.

CAR-T CDMOs manufacture engineered T-cell products, combining viral-vector transduction, T-cell activation and expansion, and rapid release testing — usually as autologous, per-patient batches on tight vein-to-vein timelines.

Choosing a CAR-T CDMO depends on autologous vs allogeneic experience, in-house vs sourced vector, closed-system processing, and chain-of-identity logistics, alongside a clean regulatory record. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 11 NAI (no action), 10 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: United States (19), Denmark (18), Germany (7), UNITED STATES (5), France (4).

Last updated 2026-07-29. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

#	CDMO	Signal Score	Quality	FDA · GMP	Capacity	Programs
1	CR Charles River Laboratories Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD	91.7	98.7	8 insp · 11 GMP	Limited	0 programs
2	BMS Bristol Myers Squibb (CGT Mfg) Bothell, WA · Warren, NJ	90.8	97.0	6 insp · 2 GMP	—	581 programs
3	COH City of Hope (T Cell Manufacturing) Duarte, CA	83.8	96.8	3 insp · 0 GMP	—	211 programs
4	MN Minaris Advanced Therapies Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP	83.5	100.0	1 insp · 6 GMP	Limited	0 programs
5	AG AGC Biologics Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP	80.6	99.9	2 insp · 23 GMP	Available	2 programs
6	RC RoslinCT Edinburgh, UK · Hopkinton, MA	80.2	98.8	1 insp · 1 GMP	Available	0 programs
7	GS GenScript ProBio Piscataway, NJ · Nanjing, CN	79.5	100.0	—	Constrained	0 programs
8	NV Novartis Contract Manufacturing Morris Plains, NJ · Stein, CH	79.1	90.9	—	Constrained	284 programs
9	FH Fred Hutch Cell Therapy Lab Seattle, WA	76.4	—	—	—	452 programs
10	GenScript Piscataway, NJ	65.5	—	—	—	0 programs
11	CT CTMC Houston, TX	63.0	—	—	—	0 programs
12	MX MaxCyte Gaithersburg, MD	62.0	—	—	—	0 programs
13	CL Cellares South San Francisco, CA	61.5	—	—	Available	0 programs
14	MS Made Scientific Princeton, NJ	61.5	—	—	—	0 programs
15	EB ElevateBio BaseCamp Waltham, MA	59.0	—	—	—	0 programs
16	AS Artis BioSolutions Lake Nona, FL	59.0	—	—	—	0 programs
17	PO Poseida Therapeutics (CDMO) San Diego, CA	58.7	—	—	—	6 programs
—	Kite Pharma (Gilead Sciences) Santa Monica, CA	Profiled	—	—	—	0 programs
—	Rose BioSolutions Wilmington, MA	Profiled	—	—	—	0 programs
—	Cellipont Bioservices The Woodlands, TX	Profiled	—	—	—	0 programs
—	Porton Advanced Cranbury, NJ	Profiled	—	—	—	0 programs
—	Landmark Bio Watertown, MA	Profiled	—	—	—	0 programs
—	Navigate BioPharma Services, Inc. Carlsbad, CA	Profiled	—	—	—	0 programs

How we score CDMOs →

What to evaluate in a CAR-T CDMO

Vector supply

CAR-T needs a lentiviral or retroviral vector. Confirm whether the CDMO produces vector in-house or coordinates a supplier, and how that affects timelines and cost.

Autologous logistics & turnaround

Autologous CAR-T lives or dies on vein-to-vein time and chain-of-identity. Evaluate scheduling, apheresis handling, and cryo-logistics.

Closed, scalable processing

Closed and automated platforms reduce contamination risk and support parallel patient slots. Ask about cleanroom grade and concurrent-batch capacity.

Regulatory track record

Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.

FDA jurisdiction — how the ranking scores US-based CDMOs

The Signal Score's Quality Compliance pillar (35% of the composite) is dominated by FDA inspection data for US-based CDMOs: Establishment Inspection Report classifications (NAI, VAI, OAI), Form 483 observation counts, and Warning Letter history. For a CDMO whose primary facility footprint is US, this pillar carries direct weight — an inspection on the site slated for a sponsor's program applies without translation. For CDMOs with mixed US + international facility footprint, the ranking reflects the composite regulatory posture; sponsors evaluating for a specific program should verify inspection history on the exact US site under consideration via that CDMO's profile page.

Which US CDMOs also cover EU and UK regulatory geographies?

Many top-tier US-based CDMOs maintain EU (EMA) and UK (MHRA) GMP certification for facilities used to supply EU and UK trials or commercial markets. The Signal Score's Quality Compliance pillar includes EMA + MHRA certificate density as a component — a US-headquartered CDMO with dense EU/UK certificates typically ranks higher on this pillar than a US-only competitor. Sponsors running dual-jurisdiction programs should cross-check the individual CDMO profile pages for specific certificate coverage; the Europe region ranking surfaces CDMOs that also appear in the European jurisdiction ranking, indicating multi-region regulatory posture.

How CDMO Signal identifies US manufacturing presence

Region attribution is derived from each CDMO's declared facility locations in our directory. A CDMO's facility list is validated against corporate filings, press releases, and — where public — the FDA facility registration (FEI number lookups). Region matching is done at the country level: a US state name or two-letter abbreviation in the facility list places the CDMO in the US region. CDMOs with US + international sites appear in every applicable region ranking, which reflects operational reality — such a CDMO is a legitimate candidate for programs in any of those jurisdictions.

CAR-T CDMOs — Frequently Asked Questions

Who are the top CAR-T CDMOs?

By CDMO Signal's independent Signal Score, the top-ranked CAR-T CDMOs include Charles River Laboratories, Bristol Myers Squibb (CGT Mfg), City of Hope (T Cell Manufacturing). See the full ranked table above — scored on FDA, clinical, financial, and capacity data.

How many CAR-T CDMOs have FDA inspection records?

CDMO Signal tracks 6 CAR-T CDMOs with FDA inspection records and 43 EMA/MHRA GMP certificates across the group.

What should I look for in a CAR-T CDMO?

Confirm vector supply (in-house or coordinated), autologous logistics and vein-to-vein turnaround, closed-system scalable processing for parallel patients, and a clean FDA and EMA/MHRA record.

Do CAR-T CDMOs make their own viral vectors?

Some produce lentiviral or retroviral vector in-house; others coordinate an external vector CDMO. In-house vector can shorten timelines and de-risk supply. Check each profile's modality coverage above.

Related modalities

Cell Therapy CDMOs Lentiviral Vector CDMOs Gene Editing CDMOs

Other Modalities

AAV Lentiviral Cell Therapy mRNA/LNP Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome Recombinant Proteins ADC